A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea
	    		
		   		
		   			 
		   		
	    	
    	 
    	10.3349/ymj.2019.60.4.375
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Yun Gyoung HUR
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Ji Young HONG
			        		
			        		;
		        		
		        		
		        		
			        		Dong Hwan CHOI
			        		
			        		;
		        		
		        		
		        		
			        		Ahreum KIM
			        		
			        		;
		        		
		        		
		        		
			        		So yeong PARK
			        		
			        		;
		        		
		        		
		        		
			        		Minsuk KWON
			        		
			        		;
		        		
		        		
		        		
			        		Kyungjoon KANG
			        		
			        		;
		        		
		        		
		        		
			        		Jeong Min LEE
			        		
			        		;
		        		
		        		
		        		
			        		Hazel M DOCKRELL
			        		
			        		;
		        		
		        		
		        		
			        		Yoonsuk LEE
			        		
			        		;
		        		
		        		
		        		
			        		Hoodon JOO
			        		
			        		;
		        		
		        		
		        		
			        		Sang Nae CHO
			        		
			        		
		        		
		        		
		        		
    Author Information Author Information
 
			        		
			        		
			        			1. Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea. hur1225@gmail.com
 
 
- Publication Type:Original Article
- Keywords:
        			
	        			
	        				
	        				
			        		
				        		ichroma™ IGRA-TB;
			        		
			        		
			        		
				        		IFN-γ;
			        		
			        		
			        		
				        		latent TB infection;
			        		
			        		
			        		
				        		point-of-care platform;
			        		
			        		
			        		
				        		QuantiFERON-TB Gold In-Tube test;
			        		
			        		
			        		
				        		tuberculosis
			        		
			        		
	        			
        			
        		
- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Diagnosis;
				        		
			        		
				        		
					        		Enzyme-Linked Immunosorbent Assay;
				        		
			        		
				        		
					        		Feasibility Studies;
				        		
			        		
				        		
					        		Healthy Volunteers;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Korea;
				        		
			        		
				        		
					        		Latent Tuberculosis;
				        		
			        		
				        		
					        		Methods;
				        		
			        		
				        		
					        		Mycobacterium tuberculosis;
				        		
			        		
				        		
					        		Point-of-Care Systems;
				        		
			        		
				        		
					        		ROC Curve;
				        		
			        		
				        		
					        		Tuberculosis
				        		
			        		
	        			
	        			
            	
            	
- From:Yonsei Medical Journal
	            		
	            		 2019;60(4):375-380
	            	
            	
- CountryRepublic of Korea
- Language:English
- 
		        	Abstract:
			       	
			       		
				        
				        	PURPOSE: This study aimed to evaluate ichroma™ IGRA-TB, a novel point-of-care platform for assaying IFN-γ release, and to compare it with QuantiFERON-TB Gold In-Tube (QFT-GIT) for identifying Mycobacterium tuberculosis (M. tb) infection. MATERIALS AND METHODS: We recruited 60 healthy subjects, and blood samples were obtained in QFT-GIT blood collection tubes. The blood collection tubes were incubated at 37℃, and culture supernatant was harvested after 18–24 hours. IFN-γ responses were assessed by the ichroma™ IGRA-TB cartridge and the QFT-GIT IFN-γ enzyme-linked immunosorbent assay. Three active TB patients were recruited as a positive control for M. tb infection. RESULTS: The area under the receiver operating characteristic curve of the ichroma™ IGRA-TB test for differentiating between infected and non-infected individuals was 0.9706 (p < 0.001). Inconsistent positivity between the two tests was found in three participants who showed weak positive IFN-γ responses ( < 1.0 IU/mL) with QFT-GIT. However, the two tests had excellent agreement (95.2%, κ=0.91, p < 0.001), and a very strong positive correlation was observed between the IFN-γ values of both tests (r=0.91, p < 0.001). CONCLUSION: The diagnostic accuracy demonstrated in this study indicates that the ichroma™ IGRA-TB test could be used as a rapid diagnostic method for detecting latent TB infection. It may be particularly beneficial in resource-limited places that require cost-effective laboratory diagnostics.